Cargando…
Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors
A very low carbohydrate ketogenic diet (VLCKD) is an emerging technique to induce a significant, well-tolerated, and rapid loss of body weight in morbidly obese patients. The low activity of lysosomal acid lipase (LAL) could be involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571559/ https://www.ncbi.nlm.nih.gov/pubmed/31067824 http://dx.doi.org/10.3390/jcm8050621 |
_version_ | 1783427436811124736 |
---|---|
author | Ministrini, Stefano Calzini, Lucia Nulli Migliola, Elisa Ricci, Maria Anastasia Roscini, Anna Rita Siepi, Donatella Tozzi, Giulia Daviddi, Giulia Martorelli, Eva-Edvige Paganelli, Maria Teresa Lupattelli, Graziana |
author_facet | Ministrini, Stefano Calzini, Lucia Nulli Migliola, Elisa Ricci, Maria Anastasia Roscini, Anna Rita Siepi, Donatella Tozzi, Giulia Daviddi, Giulia Martorelli, Eva-Edvige Paganelli, Maria Teresa Lupattelli, Graziana |
author_sort | Ministrini, Stefano |
collection | PubMed |
description | A very low carbohydrate ketogenic diet (VLCKD) is an emerging technique to induce a significant, well-tolerated, and rapid loss of body weight in morbidly obese patients. The low activity of lysosomal acid lipase (LAL) could be involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is a common feature in morbidly obese patients. Fifty-two obese patients suitable for a bariatric surgery intervention underwent a 25-day-long VLCKD. The biochemical markers of glucose and lipid metabolism, and flow-mediated dilation (FMD) of the brachial artery were measured before and after VLCKD. LAL activity was measured using the dried blood spot technique in 20 obese patients and in a control group of 20 healthy, normal-weight subjects. After VLCKD, we observed a significant reduction in body mass index, fasting glucose, insulinemia, and lipid profile parameters. No significant variation in FMD was observed. The number of patients with severe liver steatosis significantly decreased. LAL activity significantly increased, although the levels were not significantly different as compared to the control group. In conclusion, VLCKD induces the activity of LAL in morbidly obese subjects and reduces the secretion of all circulating lipoproteins. These effects could be attributed to the peculiar composition of the diet, which is particularly poor in carbohydrates and relatively rich in proteins. |
format | Online Article Text |
id | pubmed-6571559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65715592019-06-18 Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors Ministrini, Stefano Calzini, Lucia Nulli Migliola, Elisa Ricci, Maria Anastasia Roscini, Anna Rita Siepi, Donatella Tozzi, Giulia Daviddi, Giulia Martorelli, Eva-Edvige Paganelli, Maria Teresa Lupattelli, Graziana J Clin Med Article A very low carbohydrate ketogenic diet (VLCKD) is an emerging technique to induce a significant, well-tolerated, and rapid loss of body weight in morbidly obese patients. The low activity of lysosomal acid lipase (LAL) could be involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is a common feature in morbidly obese patients. Fifty-two obese patients suitable for a bariatric surgery intervention underwent a 25-day-long VLCKD. The biochemical markers of glucose and lipid metabolism, and flow-mediated dilation (FMD) of the brachial artery were measured before and after VLCKD. LAL activity was measured using the dried blood spot technique in 20 obese patients and in a control group of 20 healthy, normal-weight subjects. After VLCKD, we observed a significant reduction in body mass index, fasting glucose, insulinemia, and lipid profile parameters. No significant variation in FMD was observed. The number of patients with severe liver steatosis significantly decreased. LAL activity significantly increased, although the levels were not significantly different as compared to the control group. In conclusion, VLCKD induces the activity of LAL in morbidly obese subjects and reduces the secretion of all circulating lipoproteins. These effects could be attributed to the peculiar composition of the diet, which is particularly poor in carbohydrates and relatively rich in proteins. MDPI 2019-05-07 /pmc/articles/PMC6571559/ /pubmed/31067824 http://dx.doi.org/10.3390/jcm8050621 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ministrini, Stefano Calzini, Lucia Nulli Migliola, Elisa Ricci, Maria Anastasia Roscini, Anna Rita Siepi, Donatella Tozzi, Giulia Daviddi, Giulia Martorelli, Eva-Edvige Paganelli, Maria Teresa Lupattelli, Graziana Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title_full | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title_fullStr | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title_full_unstemmed | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title_short | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors |
title_sort | lysosomal acid lipase as a molecular target of the very low carbohydrate ketogenic diet in morbidly obese patients: the potential effects on liver steatosis and cardiovascular risk factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571559/ https://www.ncbi.nlm.nih.gov/pubmed/31067824 http://dx.doi.org/10.3390/jcm8050621 |
work_keys_str_mv | AT ministrinistefano lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT calzinilucia lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT nullimigliolaelisa lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT riccimariaanastasia lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT rosciniannarita lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT siepidonatella lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT tozzigiulia lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT daviddigiulia lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT martorellievaedvige lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT paganellimariateresa lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors AT lupattelligraziana lysosomalacidlipaseasamoleculartargetoftheverylowcarbohydrateketogenicdietinmorbidlyobesepatientsthepotentialeffectsonliversteatosisandcardiovascularriskfactors |